European Journal of Echocardiography Advance Access published online on April 4, 2008
European Journal of Echocardiography, doi:10.1093/ejechocard/jen132
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fabrys disease presenting as ventricular tachycardia and Left Ventricular Hypertrophy
1 Washington Hospital Center, 110 Irving St. NW, Washington, DC 20010, USA
2 Monash Medical Centre, Clayton, Australia
3 Royal Melbourne Hospital, Parkville, Australia
Received 26 November 2007; .
* Corresponding author. Tel: +1 202 441 8717; fax: +1 202 877 0011. E-mail address: subodh.joshi{at}gmail.com
| Abstract |
|---|
Fabrys disease (FD) is a genetic disorder leading to deficiency of
-galactosidase A. Enzymatic replacement therapy has recently become available. Patients with classical FD develop multi-system involvement; however, there is an increasingly recognized cardiac variant that presents as unexplained left ventricular hypertrophy. We describe a patient with Fabry's disease who presented with ventricular tachycardia.
Keywords: Fabry's; Ventricular tachycardia; Sudden cardiac death; Left ventricular hypertrophy